KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer
Clinical trial NCT03915405 · TERMINATED
Trial details
- NCT number
- NCT03915405
- Sponsor
- Kyowa Kirin, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2022-11-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.